Susan Greenfield Published in Oncotarget

07:27

Cancer and neurodegeneration: two sides, same coin?


By Sara Garcia-Ratés and Susan Greenfield

Susan Greenfield is a scientist, writer, broadcaster, and member of the House of Lords. She focuses her research on treatment of Parkinson's disease and Alzheimer's disease. Susan has a keen interest in the neuroscience of consciousness and the impact of technology on the brain. She has written many successful books on this subject matter and continues to published research into neuroscience.  
Susan Greenfield recently had her research published on Oncotarget, which is is a weekly peer-reviewed open access medical journal. It focus on research on all aspects of oncology. Here is a extract from the article featured in Oncotarget:
"Two papers just published would at first glance have little in common: one features a novel approach to combating metastases [1] whilst the other suggests a new strategy for treating Alzheimer’s, [2]. Nonetheless, here we describe a possible link based on the concept that both cancer and neurodegeneration are inappropriately activated forms of development, and in both cases could be mediated by the same bioactive peptide acting at the same receptor.A fundamental problem in animal biology is how the three major control processes of the body, - the endocrine, immune, and central nervous systems, - achieve the coordination that is essential for the cohesive functioning of the organism. When perturbed, such coordination could be a central, albeit overlooked, factor in the aetiology of many disease states from cancer to neurodegeneration"
Read the full Oncotarget article featuring Susan Greenfield research here, Visit Susan Greenfield website here and find out more about Susan Greenfield work in parliament here.  
   

You Might Also Like

0 comments